Related Experiment Video
Updated: Mar 16, 2026

Cell Type-specific Gene Expression Profiling in the Mouse Liver
Published on: September 17, 2019
Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and Is Activated by PPARβ/δ Deficiency
Mohammad Zarei1, Emma Barroso1, Rosana Leiva2
1Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Institute of Biomedicine of the University of Barcelona, Barcelona, Spain CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain Pediatric Research Institute, Hospital Sant Joan de Déu, Barcelona, Spain.
Abstract:
Fibroblast growth factor 21 (FGF21), a peptide hormone with pleiotropic effects on carbohydrate and lipid metabolism, is considered a target for the treatment of diabetes. We investigated the role of peroxisome proliferator-activated receptor (PPAR) β/δ deficiency in hepatic FGF21 regulation. Increased Fgf21 expression was observed in the livers of PPARβ/δ-null mice and in mouse primary hepatocytes when this receptor was knocked down by small interfering RNA (siRNA). Increased Fgf21 was associated with enhanced protein levels in the heme-regulated eukaryotic translation initiation factor 2α (eIF2α) kinase (HRI). This increase caused enhanced levels of phosphorylated eIF2α and activating transcription factor (ATF) 4, which is essential for Fgf21-induced expression. siRNA analysis demonstrated that HRI regulates Fgf21 expression in primary hepatocytes. Enhanced Fgf21 expression attenuated tunicamycin-induced endoplasmic reticulum stress, as demonstrated by using a neutralizing antibody against FGF21. Of note, increased Fgf21 expression in mice fed a high-fat diet or hepatocytes exposed to palmitate was accompanied by reduced PPARβ/δ and activation of the HRI-eIF2α-ATF4 pathway. Moreover, pharmacological activation of HRI increased Fgf21 expression and reduced lipid-induced hepatic steatosis and glucose intolerance, but these effects were not observed in Fgf21-null mice. Overall, these findings suggest that HRI is a potential target for regulating hepatic FGF21 levels.
Insights
Peroxisome proliferator-activated receptor (PPAR) β/δ deficiency increases hepatic fibroblast growth factor 21 (FGF21) via the heme-regulated eukaryotic translation initiation factor 2α (HRI) pathway. HRI activation may target hepatic FGF21 for metabolic disorders.
Area of Science:
- Metabolic Regulation
- Hormonal Signaling
Background:
- Fibroblast growth factor 21 (FGF21) regulates carbohydrate and lipid metabolism, making it a therapeutic target for diabetes.
- The role of peroxisome proliferator-activated receptor (PPAR) β/δ in hepatic FGF21 regulation remains unclear.
Purpose of the Study:
- To investigate the role of PPAR β/δ deficiency in hepatic FGF21 regulation.
- To elucidate the molecular mechanisms linking PPAR β/δ, heme-regulated eukaryotic translation initiation factor 2α (HRI), and FGF21 expression.
Main Methods:
- Utilized PPAR β/δ-null mice and primary hepatocytes with siRNA knockdown of PPAR β/δ.
- Assessed Fgf21 expression, protein levels of HRI, phosphorylated eIF2α, and activating transcription factor 4 (ATF4).
- Investigated the effect of FGF21 neutralization on endoplasmic reticulum stress and the impact of HRI pharmacological activation.
Main Results:
- PPAR β/δ deficiency and knockdown led to increased hepatic Fgf21 expression.
- Increased Fgf21 was associated with enhanced HRI, phosphorylated eIF2α, and ATF4 levels.
- HRI activation attenuated tunicamycin-induced endoplasmic reticulum stress, reduced lipid-induced hepatic steatosis, and improved glucose intolerance, effects dependent on FGF21.
Conclusions:
- PPAR β/δ deficiency activates the HRI-eIF2α-ATF4 pathway, leading to increased hepatic FGF21.
- HRI is a key regulator of hepatic FGF21 and plays a role in mitigating metabolic stress.
- HRI represents a potential therapeutic target for modulating hepatic FGF21 levels in metabolic diseases.
Related Concept Videos
Cell Specific Gene Expression
Regulation of Angiogenesis and Blood Supply
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Regulation of the Unfolded Protein Response
cAMP-dependent Protein Kinase Pathways

